Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02185105 · ClinicalTrials.gov registry record · NA
Clinical Validation of Biofinity Toric MTO (Made To Order) Lenses
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02185105 is a NA study that has completed, run by CooperVision. The registered enrollment target is 30 participants.
The verdict
NCT02185105, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The study hypothesis is there is no difference in the clinical performance between the test and control lenses, in particular in lens stability, toric mislocation, comfort ratings and anterior segment ocular health findings.
Interventions
- DEVICE comfilcon A
- DEVICE comfilcon A MTO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-06 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02185105
The ClinicalTrials.gov registry entry for NCT02185105 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which comfilcon A is the first listed.
NCT02185105 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02185105 about?
NCT02185105 is a clinical study titled "Clinical Validation of Biofinity Toric MTO (Made To Order) Lenses". The study hypothesis is there is no difference in the clinical performance between the test and control lenses, in particular in lens stability, toric mislocation, comfort ratings and anterior segment ocular health findings.
What is the current status of trial NCT02185105?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2014-06. Estimated completion is 2014-06.
What interventions are being tested in trial NCT02185105?
The interventions under investigation include: comfilcon A (DEVICE), comfilcon A MTO (DEVICE).
Who is sponsoring clinical trial NCT02185105?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.